Successful treatment of trilateral retinoblastoma with conventional and high-dose chemotherapy plus radiotherapy: a case report.


Autoria(s): De Ioris M.A.; Fidani P.; Munier F.L.; Serra A.; Ilari I.; Popovic M.B.; Natali G.; Secco D.E.; Cozza R.
Data(s)

2010

Resumo

Trilateral retinoblastoma (TRB) is a rare condition characterized by an intracranial neuroblastic tumor associated with bilateral or unilateral retinoblastoma (RB). The outcome is almost always fatal. An 18-month-old patient with familial bilateral RB was referred for a pineal lesion detected on a screening by magnetic resonance imaging. The child, considered inoperable by 2 different neurosurgical teams, was treated with conventional chemotherapy (methotrexate, vincristine, vepeside, cyclophosphamide, and carboplatin) plus tandem transplantation (vepeside/carboplatin and thiotepa/mephalan) followed by local radiotherapy. At 80 months from the diagnosis of TRB, the patient is alive and in complete remission, with no neuropsychologic consequences. An early and aggressive treatment may improve the prognosis of TRB.

Identificador

http://serval.unil.ch/?id=serval:BIB_0F14E493E4D1

isbn:1536-3678 (Electronic)

pmid:20881869

doi:10.1097/MPH.0b013e3181e90031

isiid:000283538300023

Idioma(s)

en

Fonte

Journal of Pediatric Hematology/oncology, vol. 32, no. 8, pp. e343-e345

Palavras-Chave #Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Combined Modality Therapy; Humans; Infant; Magnetic Resonance Imaging; Pinealoma/drug therapy; Pinealoma/pathology; Prognosis; Radiation Dosage; Radiotherapy; Remission Induction; Retinoblastoma/drug therapy; Retinoblastoma/pathology
Tipo

info:eu-repo/semantics/article

article